Last updated on December 2019

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

---

Brief description of study

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).